期刊文献+

ω-3脂肪酸对胃癌新辅助化疗患者术后康复中的作用研究 被引量:5

Effect of Fatty Acids Omega-3 to postoperative rehabilitation in gastric cancer undergoing neoadjuvant chemotherapy
下载PDF
导出
摘要 目的:观察ω-3脂肪酸在胃癌新辅助化疗患者术后康复中的作用。方法:选择进展期胃癌40例,采用mFOLFOX-6方案术前化疗2周期,对照组(20例)术后常规治疗,治疗组(20例),术前1d及术后6d加用ω-3脂肪酸,观察两组患者手术后康复有无差异。结果:两组患者术后2、4、6dC反应蛋白(CRP)比较,差异具有统计学意义;两组患者手术后2、4、6dSIRS(全身炎症反应综合征)发生率,切口感染、吻合口瘘发生率,及术后静脉导管相关感染、血液感染及肺部感染率比较,差异无统计学意义(P>0.05)。结论:ω-3脂肪酸能降低患者炎症反应,促进患者康复。 Objective:To evaluate the efficacy of Fatty Acids Omega-3 to postoperative rehabilitation in gastric cancer undergoing neoadjuvant chemotherapy.Methods:Patients with previously untreated advanced gastric cancer received mFOLFOX-6 neoadjuvant chemotherapy;twenty patients received Fatty Acids Omega-3 from one day preoperative to six days of postoperative the patients in the control group received basic treatment.Results:The difference of CRP 2,4,6 day of postoperative between two groups was statistically significant.Conclusion:Fatty Acids Omega-3 can degrade inflammatory reaction and encourage rehabilitation of gastric cancer undergoing neoadjuvant chemotherapy.
出处 《中国当代医药》 2011年第25期13-15,共3页 China Modern Medicine
关键词 进展期胃癌 新辅助化疗 氟尿嘧啶 奥沙利铂 根治术 Ω-3脂肪酸 Gastric cancer Neoadjuvant chemotherapy Fluorouracil Oxaliplatin Radical correction Fatty Acids Omega-3
  • 相关文献

参考文献12

  • 1李连弟,鲁凤珠,张思维,牧人,孙秀娣,皇甫小梅,孙杰,周有尚,欧阳宁慧,饶克勤,陈育德,孙爱明,薛志福,夏毅.中国恶性肿瘤死亡率20年变化趋势和近期预测分析[J].中华肿瘤杂志,1997,19(1):3-9. 被引量:869
  • 2Bone RC.Sepsis and its complications:the clinical problem[J].Grit Care Med,1994,22(7):8-11.
  • 3Friesecke S,Lotze C,Ko hler Jet al.Fish oil supplementation in the parenteral nutrition of critically ill medical patients:a randomised controlled trial[J].Intensive Care Med,2008,34(8):1411-1420.
  • 4O'Flaherty L,Bouchier-Hayes DJJmmunonutrition and surgical practice[J].Pmc Nutr Soc,1999,58(4):831-837.
  • 5Marik PE,Zaloga GP.Immunonutrition in critically ill patients:a systematic review and analysis of the literature[J].Intensive Care Med,2008,34 (11):1980-1990.
  • 6Waitzberg DL,Torrinhas RS.Fish oil lipid emulsions and immune response:what clinicians need to know[J].Nutr Clin Pract,2009,24(4):487-499.
  • 7Keam B,Im SA,Hen SW,et al.Modified FOLFOX-chemotherapy in advanced gastric cancer.Results of phase II study and comprehensive analysis of polymorphisms as a predictive and prognostic marker[J].BMC Gancer,2008,27(8):148-158.
  • 8Kim YS,Hong J,Sym SJ,et al.Oxaliplatin,5-fluorouracil and leucovorin (FOLFOX-4)combination chemotherapy as a salvage treatment in advanced gastric cancer[J].Cancer Res Treat,2010,42(1):24-29.
  • 9Lee HH,Hur H,Kim SH,et al.0utcomes of modified FOLFOX-6 as first line treatment in patients with advanced gastric cancer in a single institution; retrospective analysis[J].Cancer Res Treat,2010,42(1):18-23.
  • 10Ukaszewicz-Zajac M,Mroczko B,Szmitkowski M.The role of interleukin6 and C-reactive protein in gastric cancer[J].PoI Merkur Lekarski,2010,29(174):382-386.

二级参考文献30

共引文献899

同被引文献150

引证文献5

二级引证文献28

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部